JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HCCI
2051
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $11.9M | ﹤0.01% |
335,383
+147,315
| +78% | +$5.31M |
|
2052
Hanover Insurance
THG
$7.84B
| $11.9M | ﹤0.01% |
92,806
+9,711
| +12% | +$1.31M |
|
2053
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $11.9M | ﹤0.01% |
292,568
-19,925
| -6% | -$807K |
|
2054
UMB Financial
UMBF
$11.5B
| $11.9M | ﹤0.01% |
206,283
-16,867
| -8% | -$1.37M |
|
2055
Central Pacific Financial
CPF
$996M
| $11.9M | ﹤0.01% |
664,935
-112,157
| -14% | -$2.39M |
|
|
AZPN
2056
DELISTED
Aspen Technology Inc
AZPN
| $11.9M | ﹤0.01% |
51,965
+8,375
| +19% | +$1.74M |
|
2057
Par Pacific Holdings
PARR
$4.02B
| $11.9M | ﹤0.01% |
406,868
+213,993
| +111% | +$5.72M |
|
2058
Viavi Solutions
VIAV
$10.7B
| $11.9M | ﹤0.01% |
1,096,884
+140,956
| +15% | +$1.54M |
|
2059
LeMaitre Vascular
LMAT
$1.88B
| $11.8M | ﹤0.01% |
229,561
+13,297
| +6% | +$646K |
|
|
ROIC
2060
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $11.8M | ﹤0.01% |
845,436
+243,006
| +40% | +$3.53M |
|
2061
Euronet Worldwide
EEFT
$2.74B
| $11.8M | ﹤0.01% |
105,343
+3,629
| +4% | +$393K |
|
2062
CALL
Boston Scientific
BSX
$75.1B
| $11.8M | ﹤0.01% |
235,600
+148,600
| +171% | +$7M |
|
2063
Veeco
VECO
$3.2B
| $11.8M | ﹤0.01% |
557,535
+24,619
| +5% | +$506K |
|
2064
CALL
Costco
COST
$426B
| $11.8M | ﹤0.01% |
23,700
-35,600
| -60% | -$17.5M |
|
2065
BlueLinx
BXC
$680M
| $11.8M | ﹤0.01% |
173,164
-13,405
| -7% | -$1.08M |
|
2066
Minerals Technologies
MTX
$2.27B
| $11.8M | ﹤0.01% |
194,671
+18,882
| +11% | +$1.18M |
|
2067
Kadant
KAI
$3.95B
| $11.8M | ﹤0.01% |
56,403
+2,542
| +5% | +$516K |
|
2068
World Kinect Corp
WKC
$1.85B
| $11.7M | ﹤0.01% |
458,416
+153,332
| +50% | +$4.17M |
|
|
EVRI
2069
DELISTED
Everi Holdings
EVRI
| $11.7M | ﹤0.01% |
681,382
+36,938
| +6% | +$639K |
|
2070
Stride
LRN
$3.46B
| $11.7M | ﹤0.01% |
297,483
-9,973
| -3% | -$391K |
|
2071
PUT
Philip Morris
PM
$297B
| $11.7M | ﹤0.01% |
119,800
+30,900
| +35% | +$3.08M |
|
2072
QCR Holdings
QCRH
$1.74B
| $11.6M | ﹤0.01% |
265,119
-13,267
| -5% | -$661K |
|
2073
LivaNova
LIVN
$4.53B
| $11.6M | ﹤0.01% |
266,476
+4,435
| +2% | +$225K |
|
2074
PUT
Newmont
NEM
$124B
| $11.6M | ﹤0.01% |
236,700
+78,200
| +49% | +$3.79M |
|
2075
Syndax Pharmaceuticals
SNDX
$1.77B
| $11.6M | ﹤0.01% |
549,085
+10,959
| +2% | +$273K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,315 increased, 2,057 reduced and 651 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 651 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.